Cost-Effectiveness Analysis of PEG-rhG-CSF as Primary Prophylaxis to Chemotherapy-Induced Neutropenia in Women With Breast Cancer in China: Results Based on Real-World Data

• Main Authors: Jie Zhao (Author), Gaoxing Qiao (Author), Yan Liang (Author), Jia Li (Author), Wei Hu (Author), Xu Zuo (Author), Junfang Li (Author), Chenglong Zhao (Author), Xiaojian Zhang (Author), Shuzhang Du (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Pegylated recombinant human granulocyte colony-stimulating factors (PEG-rhG-CSFs) are more commonly and widely used than recombinant human granulocyte colony-stimulating factors (rhG-CSFs) in preventing chemotherapy-induced neutropenia in patients with stage II-IV breast cancer. To reduc...